Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice

Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs auto...

Full description

Bibliographic Details
Main Authors: Koichiro Tsujimaru, Masakatsu Takanashi, Katsuko Sudo, Akio Ishikawa, Shoichiro Mineo, Shinobu Ueda, Katsuyoshi Kumagai, Masahiko Kuroda
Format: Article
Language:English
Published: Elsevier 2020-12-01
Series:Regenerative Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352320420300699
id doaj-f91055e59c2340d4bb90eaaee247b29c
record_format Article
spelling doaj-f91055e59c2340d4bb90eaaee247b29c2020-12-23T05:00:31ZengElsevierRegenerative Therapy2352-32042020-12-0115305311Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on miceKoichiro Tsujimaru0Masakatsu Takanashi1Katsuko Sudo2Akio Ishikawa3Shoichiro Mineo4Shinobu Ueda5Katsuyoshi Kumagai6Masahiko Kuroda7Department of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanPreclinical Research Center, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanDepartment of Molecular Pathology, Tokyo Medical University, JapanPreclinical Research Center, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, JapanDepartment of Molecular Pathology, Tokyo Medical University, Japan; Corresponding author. Department of Molecular Pathology, Tokyo Medical University, 6-1-1, Shinjuku, Shinjuku-ku, Tokyo, 160-8402, Japan. Fax: +81-3-3352-6335.Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs autoimmune disease. Interestingly, IL-1 receptor antagonist deficient (IL-1ra−/−) mice induce inflammation in joints like RA. In RA therapy, although AMSC improves the inflammation activity, it is little known to play roles of extracellular microvesicles (EV) for improvement of RA. To clarify the MSC-derived EVs are involved amelioration mechanisms for RA by themselves, we examined the functional effects of development for RA by AMSC-EVs. Methods: We isolated AMSCs derived mice adipose tissue and purified EVs from the culture supernatant of AMSCs. To examine whether EVs can improve RA, we administrated EVs or AMSCs to IL-1ra knockout mice as RA model mice. We analyzed EVs-included factor by western blot methods and RA improvement effect by ELISA. Results: In this study, we showed that the swellings of joints on mice in wild type AMSC and that in AMSC-EVs decreased than that in IL-1ra−/− mice-AMSC-EVs and in none-treated. We detected IL-1ra expression in AMSC-EVs in wild type mice but not that in IL-1ra−/− mice. Proinflammatory cytokine expression changes in mice showed in AMSCs and AMSC-EVs, but no apparent differences cytokine expressions were detected in IL-1ra−/− mice. Conclusions: In this study, we concluded that MSCs might improve RA by the transferring of factors such as IL-1ra, which are included their MSC derived- EVs.http://www.sciencedirect.com/science/article/pii/S2352320420300699Adipose-derived mesenchymal stem cellsExtracellular vesicleIL-1 receptor antagonistArthritis
collection DOAJ
language English
format Article
sources DOAJ
author Koichiro Tsujimaru
Masakatsu Takanashi
Katsuko Sudo
Akio Ishikawa
Shoichiro Mineo
Shinobu Ueda
Katsuyoshi Kumagai
Masahiko Kuroda
spellingShingle Koichiro Tsujimaru
Masakatsu Takanashi
Katsuko Sudo
Akio Ishikawa
Shoichiro Mineo
Shinobu Ueda
Katsuyoshi Kumagai
Masahiko Kuroda
Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
Regenerative Therapy
Adipose-derived mesenchymal stem cells
Extracellular vesicle
IL-1 receptor antagonist
Arthritis
author_facet Koichiro Tsujimaru
Masakatsu Takanashi
Katsuko Sudo
Akio Ishikawa
Shoichiro Mineo
Shinobu Ueda
Katsuyoshi Kumagai
Masahiko Kuroda
author_sort Koichiro Tsujimaru
title Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
title_short Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
title_full Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
title_fullStr Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
title_full_unstemmed Extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
title_sort extracellular microvesicles that originated adipose tissue derived mesenchymal stem cells have the potential ability to improve rheumatoid arthritis on mice
publisher Elsevier
series Regenerative Therapy
issn 2352-3204
publishDate 2020-12-01
description Introduction: Mesenchymal stem cells (MSCs) are promising therapeutic tools in regenerative medicine. In particularly adipose tissue derived MSC (AMSC) has powerful potential for the therapeutics of rheumatoid arthritis (RA) because these cells can control immune balance. RA systemically occurs autoimmune disease. Interestingly, IL-1 receptor antagonist deficient (IL-1ra−/−) mice induce inflammation in joints like RA. In RA therapy, although AMSC improves the inflammation activity, it is little known to play roles of extracellular microvesicles (EV) for improvement of RA. To clarify the MSC-derived EVs are involved amelioration mechanisms for RA by themselves, we examined the functional effects of development for RA by AMSC-EVs. Methods: We isolated AMSCs derived mice adipose tissue and purified EVs from the culture supernatant of AMSCs. To examine whether EVs can improve RA, we administrated EVs or AMSCs to IL-1ra knockout mice as RA model mice. We analyzed EVs-included factor by western blot methods and RA improvement effect by ELISA. Results: In this study, we showed that the swellings of joints on mice in wild type AMSC and that in AMSC-EVs decreased than that in IL-1ra−/− mice-AMSC-EVs and in none-treated. We detected IL-1ra expression in AMSC-EVs in wild type mice but not that in IL-1ra−/− mice. Proinflammatory cytokine expression changes in mice showed in AMSCs and AMSC-EVs, but no apparent differences cytokine expressions were detected in IL-1ra−/− mice. Conclusions: In this study, we concluded that MSCs might improve RA by the transferring of factors such as IL-1ra, which are included their MSC derived- EVs.
topic Adipose-derived mesenchymal stem cells
Extracellular vesicle
IL-1 receptor antagonist
Arthritis
url http://www.sciencedirect.com/science/article/pii/S2352320420300699
work_keys_str_mv AT koichirotsujimaru extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT masakatsutakanashi extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT katsukosudo extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT akioishikawa extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT shoichiromineo extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT shinobuueda extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT katsuyoshikumagai extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
AT masahikokuroda extracellularmicrovesiclesthatoriginatedadiposetissuederivedmesenchymalstemcellshavethepotentialabilitytoimproverheumatoidarthritisonmice
_version_ 1724373598352703488